Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2021

SKU ID :QYR-17143513 | Published Date: 09-Jan-2021 | No. of pages: 99
1 Congestive Heart Failure (CHF) Treatment Devices Market Overview 1.1 Product Overview and Scope of Congestive Heart Failure (CHF) Treatment Devices 1.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type 1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Cardiac Resynchronization Therapy (CRT) 1.2.3 Implantable Cardioverter Defibrillators (ICDs) 1.3 Congestive Heart Failure (CHF) Treatment Devices Segment by Application 1.3.1 Congestive Heart Failure (CHF) Treatment Devices Sales Comparison by Application: (2021-2027) 1.3.2 Left Ventricular Assist Device (LVAD) 1.3.3 Right Ventricular Assist Device (RVAD) 1.3.4 Biventricular Assist Device (BIVAD) 1.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Estimates and Forecasts 1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2016-2027 1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027 1.4.3 Congestive Heart Failure (CHF) Treatment Devices Market Size by Region: 2016 Versus 2021 Versus 2027 2 Congestive Heart Failure (CHF) Treatment Devices Market Competition by Manufacturers 2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2016-2021) 2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Sites, Area Served, Product Type 2.5 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Situation and Trends 2.5.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue 2.5.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario by Region 3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 3.3.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country 3.3.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 3.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country 3.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Region 3.5.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region 3.5.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 3.6.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country 3.6.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 3.7.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country 3.7.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Analysis by Type 4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021) 4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2016-2021) 4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2021) 5 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Analysis by Application 5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021) 5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2016-2021) 5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Abiomed 6.1.1 Abiomed Corporation Information 6.1.2 Abiomed Description and Business Overview 6.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Abiomed Product Portfolio 6.1.5 Abiomed Recent Developments/Updates 6.2 Berlin Heart GmbH 6.2.1 Berlin Heart GmbH Corporation Information 6.2.2 Berlin Heart GmbH Description and Business Overview 6.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Berlin Heart GmbH Product Portfolio 6.2.5 Berlin Heart GmbH Recent Developments/Updates 6.3 Biotronik SE & Co. KG 6.3.1 Biotronik SE & Co. KG Corporation Information 6.3.2 Biotronik SE & Co. KG Description and Business Overview 6.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Biotronik SE & Co. KG Product Portfolio 6.3.5 Biotronik SE & Co. KG Recent Developments/Updates 6.4 Boston Scientific Corporation 6.4.1 Boston Scientific Corporation Corporation Information 6.4.2 Boston Scientific Corporation Description and Business Overview 6.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Boston Scientific Corporation Product Portfolio 6.4.5 Boston Scientific Corporation Recent Developments/Updates 6.5 HeartWare International 6.5.1 HeartWare International Corporation Information 6.5.2 HeartWare International Description and Business Overview 6.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.5.4 HeartWare International Product Portfolio 6.5.5 HeartWare International Recent Developments/Updates 6.6 Jarvik Heart 6.6.1 Jarvik Heart Corporation Information 6.6.2 Jarvik Heart Description and Business Overview 6.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Jarvik Heart Product Portfolio 6.6.5 Jarvik Heart Recent Developments/Updates 6.7 LivaNova PLC 6.6.1 LivaNova PLC Corporation Information 6.6.2 LivaNova PLC Description and Business Overview 6.6.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 LivaNova PLC Product Portfolio 6.7.5 LivaNova PLC Recent Developments/Updates 6.8 Medtronic 6.8.1 Medtronic Corporation Information 6.8.2 Medtronic Description and Business Overview 6.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Medtronic Product Portfolio 6.8.5 Medtronic Recent Developments/Updates 6.9 ReliantHeart 6.9.1 ReliantHeart Corporation Information 6.9.2 ReliantHeart Description and Business Overview 6.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.9.4 ReliantHeart Product Portfolio 6.9.5 ReliantHeart Recent Developments/Updates 6.10 Abbott 6.10.1 Abbott Corporation Information 6.10.2 Abbott Description and Business Overview 6.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Abbott Product Portfolio 6.10.5 Abbott Recent Developments/Updates 7 Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Analysis 7.1 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices 7.4 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Congestive Heart Failure (CHF) Treatment Devices Distributors List 8.3 Congestive Heart Failure (CHF) Treatment Devices Customers 9 Congestive Heart Failure (CHF) Treatment Devices Market Dynamics 9.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends 9.2 Congestive Heart Failure (CHF) Treatment Devices Growth Drivers 9.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges 9.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints 10 Global Market Forecast 10.1 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Type (2022-2027) 10.2 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Application (2022-2027) 10.3 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Covered in This Study Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2016-2021) Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Congestive Heart Failure (CHF) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Sites and Area Served Table 11. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) & (K Units) Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021) Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 19. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 20. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 22. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 23. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 24. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021) Table 30. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 31. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 32. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2016-2021) Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021) Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (Million US$) by Type (2016-2021) Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2016-2021) Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2016-2021) Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2016-2021) Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021) Table 45. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (Million US$) by Application (2016-2021) Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2016-2021) Table 47. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2016-2021) Table 48. Abiomed Corporation Information Table 49. Abiomed Description and Business Overview Table 50. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Table 52. Abiomed Recent Developments/Updates Table 53. Berlin Heart GmbH Corporation Information Table 54. Berlin Heart GmbH Description and Business Overview Table 55. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Table 57. Berlin Heart GmbH Recent Developments/Updates Table 58. Biotronik SE & Co. KG Corporation Information Table 59. Biotronik SE & Co. KG Description and Business Overview Table 60. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Table 62. Biotronik SE & Co. KG Recent Developments/Updates Table 63. Boston Scientific Corporation Corporation Information Table 64. Boston Scientific Corporation Description and Business Overview Table 65. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Table 67. Boston Scientific Corporation Recent Developments/Updates Table 68. HeartWare International Corporation Information Table 69. HeartWare International Description and Business Overview Table 70. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Table 72. HeartWare International Recent Developments/Updates Table 73. Jarvik Heart Corporation Information Table 74. Jarvik Heart Description and Business Overview Table 75. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Table 77. Jarvik Heart Recent Developments/Updates Table 78. LivaNova PLC Corporation Information Table 79. LivaNova PLC Description and Business Overview Table 80. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Table 82. LivaNova PLC Recent Developments/Updates Table 83. Medtronic Corporation Information Table 84. Medtronic Description and Business Overview Table 85. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Table 87. Medtronic Recent Developments/Updates Table 88. ReliantHeart Corporation Information Table 89. ReliantHeart Description and Business Overview Table 90. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Table 92. ReliantHeart Recent Developments/Updates Table 93. Abbott Corporation Information Table 94. Abbott Description and Business Overview Table 95. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Table 97. Abbott Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Congestive Heart Failure (CHF) Treatment Devices Distributors List Table 101. Congestive Heart Failure (CHF) Treatment Devices Customers List Table 102. Congestive Heart Failure (CHF) Treatment Devices Market Trends Table 103. Congestive Heart Failure (CHF) Treatment Devices Growth Drivers Table 104. Congestive Heart Failure (CHF) Treatment Devices Market Restraints Table 105. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2022-2027) & (K Units) Table 106. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Type (2022-2027) Table 107. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2022-2027) & (K Units) Table 110. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2022-2027) Table 111. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2022-2027) & (K Units) Table 114. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Region (2022-2027) Table 115. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Congestive Heart Failure (CHF) Treatment Devices Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Type in 2020 & 2027 Figure 3. Cardiac Resynchronization Therapy (CRT) Product Picture Figure 4. Implantable Cardioverter Defibrillators (ICDs) Product Picture Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application in 2020 & 2027 Figure 6. Left Ventricular Assist Device (LVAD) Figure 7. Right Ventricular Assist Device (RVAD) Figure 8. Biventricular Assist Device (BIVAD) Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size 2016-2027 (US$ Million) Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027 (K Units) Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers in 2020 Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players: Market Share by Revenue in 2020 Figure 16. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021) Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2020 Figure 19. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021) Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2020 Figure 21. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Type (2016-2021) Figure 46. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2016-2021) Figure 47. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application in 2020 Figure 48. Revenue Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2016-2021) Figure 49. Revenue Share of Congestive Heart Failure (CHF) Treatment Devices by Application in 2020 Figure 50. Manufacturing Cost Structure of Congestive Heart Failure (CHF) Treatment Devices Figure 51. Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices Figure 52. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed
Abiomed Berlin Heart GmbH Biotronik SE & Co. KG Boston Scientific Corporation HeartWare International Jarvik Heart LivaNova PLC Medtronic ReliantHeart Abbott
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients